Gene Research Foundation develops DNA activator

Gene Research Foundation, part of Dr Agarwal Hospitals and Manacells, has set a new benchmark in the field of healthcare by developing a product called Mana (DNA activator) wherein a patient is treated for disorders by replacing the defective gene with a new one. Many of these genes play a role in diverse clinical situations—from severe intellectual disability to adult-onset schizophrenia.

View the original article here: Gene Research Foundation develops DNA activator – Express Healthcare

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.